[PHARMA] QoQ Quarter Result on 30-Jun-2019 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
23-Aug-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
30-Jun-2019 [#2]
Profit Trend
QoQ- -52.69%
YoY- 72.06%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 819,921 715,683 716,849 601,890 786,108 596,644 587,660 24.83%
PBT 30,880 -238,474 3,885 12,481 30,243 11,940 17,603 45.40%
Tax -8,465 59,741 -3,509 -3,219 -10,595 -7,370 -2,298 138.32%
NP 22,415 -178,733 376 9,262 19,648 4,570 15,305 28.93%
-
NP to SH 22,399 -178,598 481 9,281 19,617 4,437 15,051 30.31%
-
Tax Rate 27.41% - 90.32% 25.79% 35.03% 61.73% 13.05% -
Total Cost 797,506 894,416 716,473 592,628 766,460 592,074 572,355 24.72%
-
Net Worth 350,047 336,573 516,387 518,564 528,825 509,862 522,618 -23.42%
Dividend
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Div 15,673 - - 6,514 15,630 5,202 13,000 13.26%
Div Payout % 69.98% - - 70.19% 79.68% 117.26% 86.38% -
Equity
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Net Worth 350,047 336,573 516,387 518,564 528,825 509,862 522,618 -23.42%
NOSH 261,229 261,229 261,229 261,229 260,505 260,505 260,505 0.18%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin 2.73% -24.97% 0.05% 1.54% 2.50% 0.77% 2.60% -
ROE 6.40% -53.06% 0.09% 1.79% 3.71% 0.87% 2.88% -
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
RPS 313.87 274.30 274.86 230.98 301.76 229.36 226.02 24.44%
EPS 8.57 -68.45 0.18 3.56 7.53 1.71 5.79 29.84%
DPS 6.00 0.00 0.00 2.50 6.00 2.00 5.00 12.91%
NAPS 1.34 1.29 1.98 1.99 2.03 1.96 2.01 -23.66%
Adjusted Per Share Value based on latest NOSH - 261,229
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
RPS 56.89 49.66 49.74 41.76 54.54 41.40 40.77 24.84%
EPS 1.55 -12.39 0.03 0.64 1.36 0.31 1.04 30.44%
DPS 1.09 0.00 0.00 0.45 1.08 0.36 0.90 13.60%
NAPS 0.2429 0.2335 0.3583 0.3598 0.3669 0.3538 0.3626 -23.42%
Price Multiplier on Financial Quarter End Date
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Date 31/03/20 31/12/19 30/09/19 28/06/19 29/03/19 31/12/18 28/09/18 -
Price 1.26 2.06 2.44 2.84 2.27 2.78 2.89 -
P/RPS 0.40 0.75 0.89 1.23 0.75 1.21 1.28 -53.91%
P/EPS 14.69 -3.01 1,322.99 79.74 30.14 162.99 49.93 -55.73%
EY 6.81 -33.23 0.08 1.25 3.32 0.61 2.00 126.16%
DY 4.76 0.00 0.00 0.88 2.64 0.72 1.73 96.23%
P/NAPS 0.94 1.60 1.23 1.43 1.12 1.42 1.44 -24.72%
Price Multiplier on Announcement Date
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Date 19/05/20 20/02/20 20/11/19 23/08/19 16/05/19 21/02/19 19/11/18 -
Price 1.88 2.04 2.21 2.66 2.36 2.76 3.09 -
P/RPS 0.60 0.74 0.80 1.15 0.78 1.20 1.37 -42.30%
P/EPS 21.93 -2.98 1,198.28 74.69 31.34 161.81 53.38 -44.70%
EY 4.56 -33.55 0.08 1.34 3.19 0.62 1.87 81.07%
DY 3.19 0.00 0.00 0.94 2.54 0.72 1.62 57.03%
P/NAPS 1.40 1.58 1.12 1.34 1.16 1.41 1.54 -6.15%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment